PROGESTERONE RECEPTOR ANTAGONISTS
    4.
    发明申请
    PROGESTERONE RECEPTOR ANTAGONISTS 有权
    孕激素受体拮抗剂

    公开(公告)号:US20130072464A1

    公开(公告)日:2013-03-21

    申请号:US13578500

    申请日:2011-02-08

    IPC分类号: C07J43/00 C07J41/00

    摘要: The invention relates to 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives of formula I with progesterone-antagonizing action and methods of production thereof, use thereof for the treatment and/or prevention of diseases and use thereof for producing medicinal products for the treatment and/or prevention of diseases, in particular uterine fibroids (myomata, uterine leiomyomata), endometriosis, heavy menstrual bleeding, meningiomata, hormone-dependent breast cancers and menopause-associated complaints or for fertility control and emergency contraception.

    摘要翻译: 本发明涉及式I的17-羟基-17-五氟乙基 - 雌-4,9(10) - 二烯-11-芳基衍生物与孕酮拮抗作用及其生产方法,其用于治疗和/或预防 的疾病及其用于生产用于治疗和/或预防疾病的药物的用途,特别是子宫肌瘤(肌瘤,子宫平滑肌瘤),子宫内膜异位症,重度月经出血,脑膜炎,激素依赖性乳腺癌和绝经相关的投诉或用于 生育控制和紧急避孕。